Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-26-022980

Chief Operating Officer sold 7,500 shares at an average $6.09 ($45,680)

  • Chief Operating Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ye Weiguo · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-22 Exercise or conversion : show line 1 in the form +3,500 $0.75 $2,625 703,500 D
2026-05-22 Sale : show line 2 in the form −3,500 $6.08 $21,280 700,000 D
2026-05-26 Exercise or conversion : show line 3 in the form +4,000 $0.75 $3,000 704,000 D
2026-05-26 Sale : show line 4 in the form −4,000 $6.10 $24,400 700,000 D
Open-market sales · 7,500 sh · avg $6.09 · $45,680

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-22 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −3,500 901,395 D
2026-05-26 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −4,000 897,395 D
Loading xslF345X06/form4.xml…